Purpose: To assess the effects of transcorneal electrical stimulation (TES) on several measures of visual function in retinitis pigmentosa. Methods: This prospective, randomized, fellow-eye–controlled study includes 30 eyes of 15 patients with retinitis pigmentosa. Each patient's eyes were randomly selected as treatment (TE) and control eye (CE), and 30 minutes/week TES was applied for 6 months. Patient evaluations were performed before and after TES, including comprehensive ophthalmological examination, visual fields, full-field and multifocal electroretinography, microperimetry, and optical coherence tomography. All parameters were compared before and after TES and between TE and CE. Results: After TES, the mean signal amplitudes in multifocal electroretinography were stabilized in TE. The mean signal amplitudes in CE decreased in every ring, reaching significance in the fifth ring (847.15 ± 393.94 and 678.77 ± 282.66 nV, P = 0.039, before and after TES, respectively). The changes in the mean signal amplitudes of TE and CE were −0.38 ± 295.53 and −185.15 ± 332,62 nV in second (P = 0.046), 36.69 ± 326.4 and −143.38 ± 317,41 nV in fourth (P = 0.028), and −17.46 ± 333.07 and −168.38 ± 297,14 nV in fifth rings (P = 0.046), respectively. The decrease in the mean signal amplitudes between 2° and 20° midperipheral retina was significantly less in TE (−33.59 ± 225,1 nV) than CE (−205.56 ± 345.1 nV) (P = 0.011). There were no significant changes in other parameters. Conclusion: The progression in multifocal electroretinography might be stabilized with TES. Further studies with larger sample sizes and a longer follow-up are needed to conclude that TES reduces retinitis pigmentosa progression.
Purpose: To assess the peripapillary choroidal vasculature in paediatric myopic patients with and without peripapillary hyperreflective ovoid mass‐like structures (PHOMS).Methods: This prospective study includes 60 eyes of 60 myopic (spherical equivalent [SE] <−1.00 dioptre [D]) patients with (n = 30) and without (n = 30) PHOMS (PHOMS [+] and PHOMS [−] groups, respectively), and 30 eyes of 30 age‐ and sex‐matched emmetropic children (control group). Peripapillary choroidal parameters, including total choroidal (TCA), luminal (LA), and stromal areas (SA) and choroidal vascularity index (CVI) calculated from vertical and horizontal single‐line enhanced depth imaging‐optical coherence tomography scans centred on optic nerve head.Results: Peripapillary retinal nerve fibre layer thicknesses were not different between the groups (p > 0.05). In the PHOMS (+) group, TCA, LA and SA were lower, and CVI was higher in all quadrants compared to the control (p < 0.05). However, only the mean TCA and LA in the inferior and nasal quadrants and the mean SA in the nasal quadrant were lower in PHOMS (+) than in PHOMS (−) (p < 0.05). In the PHOMS (−) group, higher CVI was observed in all quadrants except temporal compared to the control group. Although the mean CVI of the PHOMS (+) group was also higher than in the PHOMS (−) group, this difference was not statistically significant.Conclusion: This study indicates that choroidal parameters differ in paediatric myopic patients with PHOMS. Further studies with larger sample sizes are needed to understand the details of choroidal parameters in eyes with PHOMS.
Objective: Patients widely use artificial intelligence-based chatbots, and this study aims to determine their utility and limitations on questions about strabismus. The answers to the common questions about the management of strabismus provided by Chat Generative Pre-trained Transformer (ChatGPT)-3.5, an artificial intelligence-powered chatbot, were compared to answers from a strabismus specialist (The Specialist) in terms of appropriateness and readability. Patients and Methods: In this descriptive, cross-sectional study, a list of questions from strabismus patients or caregivers in outpatient clinics about treatment, prognosis, postoperative care, and complications were subjected to ChatGPT and The Specialist. The answers of ChatGPT were classified as appropriate or not, considering the answers of The Specialist as the reference. The readability of all the answers was assessed according to the parameters of the Readable online toolkit. Results: All answers provided by ChatGPT were classified as appropriate. The mean Flesch Kincaid Grade Levels of the respective answers given by ChatGPT and The Specialist were 13.75±1.55 and 10.17±2.17 (p
1 July 2025 in Acibadem Universitesi Saglik Bilimleri Dergisi
Purpose: To compare the functional, anatomical, and safety results of intravitreal biosimilar bevacizumab-awwb (IVB-awwb; Mvasi®) and reference bevacizumab (IVB; Altuzan®) in patients with neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and macular edema secondary to retinal vein occlusion (RVO). Methods: This non-randomized, retrospective, real-life study included 191 treatment-naïve eyes (62 nAMD, 96 DME, and 33 RVO) of 150 patients receiving three monthly IVB and IVB-awwb loading doses. Baseline and final (one month after the third injection) best-corrected visual acuity (BCVA; logMAR) and central macular thickness (CMT; µm) of the eyes with nAMD, DME, and RVO, disease activity rates for nAMD, and overall endophthalmitis rates were compared between IVB and IVB-awwb groups. Results: The mean baseline and final BCVA and CMT were comparable for nAMD (32 vs. 30 eyes), DME (47 vs. 49 eyes), and RVO (14 vs. 19 eyes) in IVB and IVB-awwb groups. The final nAMD activity rates were 53.1% and 63.3% in the groups, respectively (p=0.578). In DME eyes, BCVA significantly improved in the IVB group (p=0.002) with no significant difference in the IVB-awwb group (p=0.152), and the mean change in BCVA was -0.180.38 and -0.090.45 logMAR, respectively (p=0.033). Culture-negative endophthalmitis (n=2; 2.0% overall) was observed only in the IVB-awwb group (p=0.498). Conclusion: This real-life study suggests that intravitreal biosimilar bevacizumab-awwb could yield comparable or worse but no better results than reference bevacizumab in eyes with nAMD, DME, and macular edema secondary to RVO. Further randomized studies are required to elucidate the efficacy and safety of IVB-awwb.